Elizabeth Kurien, MD, CM, FRCPC
Tom Baker Cancer Centre; Calgary, BC

Session Description

This presentation will review the role for curative intent radiotherapy in the management of early stage lung cancer, including stereotactic body radiotherapy (SBRT). It will identify risk factors and patient selection criteria. The presentation will provide an overview of the expected benefits, risks, and outcomes.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • Describe the role of stereotactic body radiotherapy (SBRT) and curative intent radiotherapy in the management of early stage lung cancer.
  • Review patient selection criteria.
  • Summarize expected toxicities and outcomes.

CanMEDS Roles: Collaborator, Communicator, Medical Expert